← Back to Search

Aim 1. Focus Groups for Brain Tumor

N/A
Waitlist Available
Led By Maria Swartz, MD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights

Study Summary

This trial will test a new active video game-centered lifestyle physical activity intervention for adolescents and young adults who are at very high-risk for steep functional decline after surgery for a central nervous system tumor.

Eligible Conditions
  • Brain Tumor
  • Exercise
  • Tumors

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Quality of Life Questionnaire

Trial Design

2Treatment groups
Experimental Treatment
Group I: Aim 2. Pilot randomized controlled trial:Experimental Treatment1 Intervention
AYAs with primary benign or malignant central nervous system tumors (n=80 patients approached, with n= 40 participants consented and randomized to the intervention (n=20) or usual care control group (n=20)) treated at MDACC, any gender and race, who are ≤1-year post-surgery for a central nervous system tumor.
Group II: Aim 1. Focus GroupsExperimental Treatment1 Intervention
Healthcare providers (n=16-24 participants in 4 focus groups) from MD Anderson Cancer Center (MDACC). AYAs with primary benign or malignant central nervous system tumors (n=16-24 participants in 4 focus groups) treated at MDACC.

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
2,987 Previous Clinical Trials
1,798,219 Total Patients Enrolled
Maria Swartz, MDPrincipal InvestigatorM.D. Anderson Cancer Center
1 Previous Clinical Trials
40 Total Patients Enrolled

Media Library

POWER UP Clinical Trial Eligibility Overview. Trial Name: NCT05308407 — N/A
Brain Tumor Research Study Groups: Aim 1. Focus Groups, Aim 2. Pilot randomized controlled trial:
Brain Tumor Clinical Trial 2023: POWER UP Highlights & Side Effects. Trial Name: NCT05308407 — N/A
POWER UP 2023 Treatment Timeline for Medical Study. Trial Name: NCT05308407 — N/A
~6 spots leftby Oct 2025